In Silico Three Dimensional Pharmacophore Models to Aid the Discovery and Design of New Antimalarial Agents

Malaria is one of the most dangerous diseases affecting primarily poor people of tropical and subtropical regions. The search for novel drugs against specific parasites is an important goal for antimalarial drug discovery. This study describes how 3D pharmacophores for antimalarial activity could be developed from known antimalarials and be used as screening tools for virtual compound libraries to identify new antimalarial candidates with examples of indolo[2,1-b]quinazoline-6,12-diones (tryptanthrins) that exhibited in vitro activity below 100 ng/mL. These models mapped on the potent analogues and also onto other well-known antimalarial drugs of different chemical classes including quinolines, chalcones, rhodamine dyes, Pfmrk CDK inhibitors, malarial KASIII inhibitors, and plasmepsin inhibitors. The pharmacophores allowed search and identification of new antimalarials from in-house multi-conformer 3D CIS database and enabled custom designed synthesis of new potent analogues that are found to be potent against in vitro W2, D6, and TM91C235 strains of P. falciparum.

[1]  P. Wilairat,et al.  Antimalarial Alkoxylated and Hydroxylated Chalones: Structure−Activity Relationship Analysis , 2001 .

[2]  Nicholas Bodor,et al.  Computer-aided drug design: the role of quantitative structure-property, structure-activity and structure-metabolism relationships (QSPR, QSAR, QSMR) , 2002 .

[3]  Jonathan L. Vennerstrom,et al.  A 3D QSAR Pharmacophore Model and Quantum Chemical Structure-Activity Analysis of Chloroquine(CQ)-Resistance Reversal , 2002, J. Chem. Inf. Comput. Sci..

[4]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[5]  S. Prigge,et al.  A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors. , 2004, Journal of medicinal chemistry.

[6]  W. Milhous,et al.  Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates. , 2004, European journal of medicinal chemistry.

[7]  M. Avery,et al.  Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials. , 1999, Current pharmaceutical design.

[8]  Hye-Sook Kim,et al.  Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity. , 2002, Journal of medicinal chemistry.

[9]  J. Karle,et al.  Stereoelectronic properties of antimalarial artemisinin analogues in relation to neurotoxicity. , 1999, Chemical research in toxicology.